235 related articles for article (PubMed ID: 2329602)
1. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Martin DC; Tertzakian G; Ruzics E
J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
[TBL] [Abstract][Full Text] [Related]
2. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Tilney NL; Chang A; Milford EL; Whitley WD; Lazarus JM; Ramos EL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1991 Jul; 214(1):42-9. PubMed ID: 2064470
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for second renal allografts immunosuppressed with cyclosporine.
Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
[TBL] [Abstract][Full Text] [Related]
4. Results with cyclosporine in renal transplantation in patients who have lost two previous allografts.
Ladowski JS; Rosenthal JT; Taylor RJ; Starzl TE; Carpenter B; Gordon R; Iwatsuki S; Hakala TR
Surg Gynecol Obstet; 1987 Jun; 164(6):553-6. PubMed ID: 3296255
[TBL] [Abstract][Full Text] [Related]
5. Does cyclosporine influence the results of cadaver retransplantation?
Flechner SM; Lorber MI; Kerman RH; Van Buren CT; Wideman C; Kahan BD
Hum Immunol; 1985 Nov; 14(3):305-13. PubMed ID: 3902748
[TBL] [Abstract][Full Text] [Related]
6. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
Wrenshall LE; Matas AJ; Canafax DM; Min DI; Sibley RJ; Dunn DL; Payne WD; Sutherland DE; Najarian JS
Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291
[TBL] [Abstract][Full Text] [Related]
7. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
8. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy immunosuppression in cadaveric renal transplantation.
Richardson AJ; Higgins RM; Ratcliffe PJ; Ting A; Murie J; Morris PJ
Transpl Int; 1990 May; 3(1):26-31. PubMed ID: 2369478
[TBL] [Abstract][Full Text] [Related]
10. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
[No Abstract] [Full Text] [Related]
11. Renal function and somatic growth in pediatric cadaveric renal transplantation with cyclosporine-prednisone immunosuppression.
Ellis D; Avner ED; Rosenthal JT; Taylor RJ; Young LW; Palumbi MA; Hakala TR
Am J Dis Child; 1985 Nov; 139(11):1161-7. PubMed ID: 3904407
[TBL] [Abstract][Full Text] [Related]
12. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
[No Abstract] [Full Text] [Related]
13. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitized patients with delayed graft function: a management protocol.
Hickey DP; Vivas CA; Jordan ML; Lopatin WB; Hrebinko R; O'Donovan R; Hakala TR
J Urol; 1991 Jan; 145(1):131-4. PubMed ID: 1984070
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
Ettenger RB; Rosenthal JT; Marik J; Forsythe S; Malekzadeh MH; Kamil E; Salusky IB; Fine RN
Transplant Proc; 1989 Feb; 21(1 Pt 2):1693-5. PubMed ID: 2652554
[No Abstract] [Full Text] [Related]
16. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
Henry ML; Sommer BG; Ferguson RM
Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
[TBL] [Abstract][Full Text] [Related]
18. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
Shield CF
Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
20. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
